WASHINGTON (AP) — The Food and Drug Administration commissioner's effort to drastically shorten the review of drugs favored by President Donald Trump's administration is causing alarm across the ...
At an employee town hall, FDA leaders tried to quell staff concerns about a controversial new program to fast-track certain ...
Senators on Thursday pressed President Donald Trump’s pick to lead the Food and Drug Administration on the agency’s recent cancellation of a vaccine advisory committee meeting as well as his policy ...
FDA Commissioner Dr. Marty Makary spoke exclusively with "Good Morning America" about updating guidelines for the "no ...
A generic version of the drug, mifepristone, was approved by the FDA in 2019. In this April 13, 2023, file photo, packages of Mifepristone tablets are displayed at a family planning clinic in ...
(NewsNation) — FDA Commissioner Dr. Marty Makary said the agency is advancing medical cures at record speed and predicts “incredible cures” will emerge over the next couple of years as the Trump ...
Listening to Food and Drug Administration (FDA) leadership, it’s easy to think that 2025 was a banner year for patient choice. On Dec. 19, Food and Drugs Commissioner Dr. Marty Makary listed the FDA’s ...
In November, Sen. Bernie Sanders of Vermont and Rep. Frank Pallone of New Jersey sent a letter seeking answers to 15 questions about the FDA’s voucher program. Pallone is the top Democrat on the House ...
Elizabeth Troutman Mitchell is the White House Correspondent for "The Daily Signal." Send her an email. The Food and Drug Administration should “immediately” restore in-person dispensing requirements ...
The Senate’s health committee convened its first hearing of the year on the efficacy of the chemical abortion drug mifepristone, which requires a prescription, amid a growing push from conservatives ...
George Caldwell is a correspondent for The Daily Signal. Send an email to George. The Senate committee overseeing health policy debated abortion pill regulation in a hearing on Wednesday, where some ...